Trial intelligence / Profile preview

Fibrinogen Concentrate vs Cryoprecipitate in Traumatic Haemorrhage (FEISTY)

NCT02745041Phase 2Completed

Sponsor
Gold Coast Hospital and Health Service
Start
Dec 2016
Primary completion
Jan 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of Fibrinogen human in traumatic hemorrhage, trauma-induced coagulopathy (TIC), sponsored by Gold Coast Hospital and Health Service. Started Dec 2016; status: completed.

02

Drugs

Fibrinogen human
03

Conditions

traumatic hemorrhagetrauma-induced coagulopathy (TIC)

Beyond the preview

Go deeper on NCT02745041.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02745041.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call